Two-Year Course of Subfoveal Pigment Epithelial Detachment in Eyes with Age-Related Macular Degeneration and Visual Acuity Better than 20/40

被引:27
作者
Baba, Takayuki [1 ]
Kitahashi, Masayasu [1 ]
Kubota-Taniai, Mariko [1 ]
Oshitari, Toshiyuki [1 ]
Yamamoto, Shuichi [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chuo Ku, Chiba 2600856, Japan
基金
日本学术振兴会;
关键词
Age-related macular degeneration; Choroidal neovascularization; Polypoidal choroidopathy; Retinal pigment epithelial detachment; INTRAVITREAL BEVACIZUMAB INJECTION; POLYPOIDAL CHOROIDAL VASCULOPATHY; PHOTODYNAMIC THERAPY; CLINICAL CHARACTERISTICS; NATURAL-HISTORY; TEARS; NEOVASCULARIZATION; SECONDARY;
D O I
10.1159/000337251
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the course of subfoveal pigment epithelial detachments (PEDs) in eyes with age-related macular degeneration (AMD) and best-corrected visual acuity (BCVA) >= 20/40. Methods: Thirty-seven eyes of 35 patients with a subfoveal PED were divided into an avascular PED group (n = 11), a vascularized PED group due to polypoidal choroidal vasculopathy (PCV, n = 14) and an occult choroidal neovascularization (CNV) group (n = 12). Intravitreal bevacizumab or ranibizumab was given as needed. The BCVA, central foveal thickness, PED thickness, and lesion size were measured at baseline and at 2 years after the initial examination. Results: The BCVA did not change significantly in the avascular group, decreased from 0.06 +/- 0.11 to 0.23 +/- 0.15 logMAR units in the PCV group and from 0.12 +/- 0.12 to 0.71 +/- 0.70 logMAR units in the CNV group. At 2 years, the central foveal and PED thicknesses were not significantly different among the 3 groups, and the lesion was significantly larger in the PCV and CNV groups than in the avascular group. Conclusions: The vascularized PED cases had a poorer visual outcome than avascular PEDs with anti-VEGF drugs at the 2-year follow-up. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:102 / 109
页数:8
相关论文
共 29 条
[1]  
Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668
[2]   Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration [J].
Axer-Siegel, R ;
Ehrlich, R ;
Rosenblatt, I ;
Kramer, M ;
Priel, E ;
Yassur, Y ;
Weinberger, D .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (04) :453-459
[3]  
BIRD AC, 1991, EYE, V5, P1
[4]   Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment [J].
Bolz, Matthias ;
Michels, Stephan ;
Geitzenauer, Wolfgang ;
Prager, Franz ;
Schmidt-Erfurth, Ursula .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (06) :785-789
[5]  
Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329
[6]   Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular agerelated macular degeneration [J].
Chan, Clement K. ;
Meyer, Carsten H. ;
Gross, Jeffrey G. ;
Abraham, Prema ;
Nuthi, Asha S. D. ;
Kokame, Gregg T. ;
Lin, Steven G. ;
Rauser, Michael E. ;
Kaiser, Peter K. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (05) :541-551
[7]   Natural History of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No. 28 [J].
Cukras, Catherine ;
Agron, Elvira ;
Klein, Michael L. ;
Ferris, Frederick L., III ;
Chew, Emily Y. ;
Gensler, Gary ;
Wong, Wai T. .
OPHTHALMOLOGY, 2010, 117 (03) :489-499
[8]  
Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265
[9]  
DECKER WL, 1983, OPHTHALMOLOGY, V90, P507
[10]  
ELMAN MJ, 1986, OPHTHALMOLOGY, V93, P224